Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of intravenous infusion of 5-aza-2'-deoxycytidine on survival time of mice with L1210 leukemia.

× No keyword cloud information.

14 in total

1. 3-Deazauridine (NSC 126849): an interesting modulator of biochemical response.

Authors: W J Moriconi; M Slavik; S Taylor
Journal: Invest New Drugs Date: 1986 Impact factor: 3.850

2. Differential nuclear protein binding to 5-azacytosine-containing DNA as a potential mechanism for 5-aza-2'-deoxycytidine resistance.

Authors: L A Michalowsky; P A Jones
Journal: Mol Cell Biol Date: 1987-09 Impact factor: 4.272

3. Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML.

Authors: Joseph M Scandura; Gail J Roboz; Michelle Moh; Ewelina Morawa; Fabienne Brenet; J Robi Bose; Luis Villegas; Usama S Gergis; Sebastian A Mayer; Cindy M Ippoliti; Tania J Curcio; Ellen K Ritchie; Eric J Feldman
Journal: Blood Date: 2011-05-25 Impact factor: 22.113

4. DNA methylation in 5-aza-2'-deoxycytidine-resistant variants of C3H 10T1/2 C18 cells.

Authors: E Flatau; F A Gonzales; L A Michalowsky; P A Jones
Journal: Mol Cell Biol Date: 1984-10 Impact factor: 4.272

5. Cell cycle effects and cellular pharmacology of 5-aza-2'-deoxycytidine.

Authors: R L Momparler; J Samson; L F Momparler; G E Rivard
Journal: Cancer Chemother Pharmacol Date: 1984 Impact factor: 3.333

6. Effect of cytidine analogs on cell growth and differentiation on a human neuroblastoma line.

Authors: S Bartolucci; M Estenoz; V de Franciscis; P Carpinelli; G L Colucci; G Augusti Tocco; M Rossi
Journal: Cell Biophys Date: 1989 Aug-Oct

7. The European Medicines Agency Review of Decitabine (Dacogen) for the Treatment of Adult Patients With Acute Myeloid Leukemia: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use.

Authors: Maria Nieto; Pierre Demolis; Eliane Béhanzin; Alexandre Moreau; Ian Hudson; Beatriz Flores; Henry Stemplewski; Tomas Salmonson; Christian Gisselbrecht; David Bowen; Francesco Pignatti
Journal: Oncologist Date: 2016-04-18

8. Plasma kinetics and effects of 5,6-dihydro-5-azacytidine in mice and L1210 tumor.

Authors: D S Zaharko; J M Covey; J A Kelley
Journal: Invest New Drugs Date: 1985 Impact factor: 3.850

Review 9. Thymidine as an anticancer agent, alone or in combination. A biochemical appraisal.

Authors: P H Ellims
Journal: Cancer Chemother Pharmacol Date: 1982-12 Impact factor: 3.333

10. Comparison of the antileukaemic activity of 5 aza-2-deoxycytidine and arabinofuranosyl-cytosine in rats with myelocytic leukaemia.

Authors: D J Richel; L P Colly; E Lurvink; R Willemze
Journal: Br J Cancer Date: 1988-12 Impact factor: 7.640